Armouring Effector Cells Against Oxidative Stress to Enhance Function & Persistence of T-Cell Based Therapies
- Present preclinical findings demonstrating how oxidative stress armouring can protect TILs and maintain their antitumour activity
- Discuss how enhancing TIL resilience to oxidative damage could improve durability and therapeutic outcomes in solid tumours